Martin Hamblin GfK Restructures Global Healthcare Division

Martin Hamblin GfK Global Healthcare has announced changes to the roles of three senior directors at their London and Connecticut offices, reflecting recent business expansion.

Stephen Grundy, who was previously Joint MD of the Division, based at the UK office, becomes Managing Director of Global Business Development and Client Service. His key responsibilities will include client relationship management, co-ordination of key account business development initiatives, employee training and development, co-ordination of a global seminar plan and co ordination of the strategic plan for the healthcare business in conjunction with other senior directors.

Angela Duffy becomes MD of the Division, with a remit to develop and implement the strategic operating plan for the UK office, manage sales and client care, manage training and development of all UK based global healthcare staff and prepare an appropriate marketing strategy for the Division.

Peter Goldberg, President of Martin Hamblin GfK Inc, the US global and USA specific healthcare operation, extends his role in becoming Global Research Director for Product Development and Commercialisation. Peter will retain his role as President of the Inc office. His objectives are to identify opportunities for product development to serve the international research industry, evaluating existing products and services and investigating new ideas. He will work with internal project teams to identify client needs and bring appropriate new services to the market.

All three Directors will report to Allan Bowditch, who remains Global CEO Healthcare with overall responsibility for strategic direction of healthcare business. He explains the changes as a response to a fast-changing global marketplace and clients needs, requiring a new management structure. 'We anticipate that these changes plus the appointment of several additional senior staff will enable us to be more flexible, faster and more innovative in meeting our clients needs both on a Global, USA and UK basis'.

The Global Healthcare Division provides ad hoc research solutions for leading international pharmaceutical companies, specialising in new product development research.

For further information visit www.martinhamblin-gfk.com

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas unless otherwise stated.

• All news